7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Aerovate Therapeutics Inc
(NASDAQ:AVTE) 

AVTE stock logo

Aerovate Therapeutics is a clinical stage biopharmaceutical company whose mission is to advance novel therapeutics and to help people with rare cardiopulmonary diseases gain control over their health, and their lives.

Founded: 2018
IPO Price: $14 (Jun 29, 2021)
CEO: Tim Noyes  
Sector:
Industry:

Share this website to your friends
Aerovate Therapeutics Number of Twitter Followers
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 018.4336.8655.2973.7192.14110.57129
Aerovate Therapeutics Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.084.156.238.310.3812.4614.53Thousand
Aerovate Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.41-2.06-1.72-1.38-1.03-0.69-0.340
Aerovate Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.43-2.08-1.73-1.39-1.04-0.69-0.350
Aerovate Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.891.782.673.564.455.346.23
Aerovate Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -15.86-13.59-11.33-9.06-6.8-4.53-2.27-0
Aerovate Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.911.812.723.624.535.436.34
No extra charts and metrics for this ticker.